Financhill
Back

Akero Therapeutics Stock Predictions

Akero Therapeutics Stock Forecast

  • Over the next 52 weeks, Akero Therapeutics has on average historically risen by 52.8% based on the past 5 years of stock performance.
  • Akero Therapeutics has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
  • Is Akero Therapeutics Stock Undervalued?
    The current Akero Therapeutics [AKRO] share price is $26.76. The Score for AKRO is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • AKRO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will Akero Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Akero Therapeutics has on average historically risen by 52.8% based on the past 5 years of stock performance.

Akero Therapeutics Stock Rating

Buy
80
Akero Therapeutics (AKRO) is a Buy

Is Akero Therapeutics overpriced?

  • Akero Therapeutics has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%

Akero Therapeutics Stock Price History

Is AKRO stock going to rise?

  • The current trend is moderately bullish and AKRO is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
akerotx.com

52-Week Data

52-Week High:
53.77
52-Week Low:
11.25

Prediction Charts

Market Cap:
1.85B
Price in USD:
26.76
Volume:
646.74K
Beta:
-0.27

Technical Analysis

SMA50:
22.24
SMA100:
23.23
SMA200:
21.77
52-Wk Change:
-40.17%

Stock Predictions

  • Is Akero Therapeutics stock public?
    Yes, Akero Therapeutics is a publicly traded company.
  • What is the Akero Therapeutics stock quote today?
    The Akero Therapeutics stock price is 26.76 USD today.
  • How to buy Akero Therapeutics stock online?
    You can buy Akero Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jul-1 23.30 23.16 24.20 23.14
Jul-2 23.03 22.38 23.21 22.23
Jul-3 22.22 21.93 22.39 21.74
Jul-5 21.74 21.45 21.74 21.02
Jul-8 21.79 22.19 22.48 21.43
Jul-9 22.24 22.91 23.04 22.01
Jul-10 22.97 24.00 24.04 22.62
Jul-11 24.87 24.83 25.70 24.38
Jul-12 25.31 25.68 25.69 24.67
Jul-15 25.81 27.45 27.94 25.63
Jul-16 27.87 27.70 28.21 27.38
Jul-17 27.03 27.08 27.77 26.66
Jul-18 26.88 27.08 27.64 26.15
Jul-19 27.14 26.76 27.41 26.28

Akero Therapeutics Earnings

Akero Therapeutics Earnings Report: Per Share Akero Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Akero Therapeutics Forecast Revenue Growth

Akero Therapeutics Stock Analysis: Historical quarterly revenues per share for Akero Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.24 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.95 per share, and a decrease next year of $0.54 per share.

* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.